People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other, Pharma, Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Direct Vet Marketing, Inc. | — | Other | Series D+ | $292.6M | $3.9B | 2017 |
| Compass Therapeutics, Inc. | — | Pharma | Series D+ | $255.8M | $2.1B | 2020 |
| Avedro Inc | — | Other Health Care | Series C | $158.4M | $571.6M | 2009 |
| Compass Therapeutics LLC | — | Biotechnology | Series D+ | $132.6M | $900.7M | 2015 |
| Pooled Clinical Data Partners, Inc. | — | Other | Seed | $1.4M | $26.5M | 2010 |
| Bar Harbor Biotechnology Inc | — | Other Technology | Pre-Seed | $460K | $7.6M | 2011 |
Philip J. Ferneau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip J. Ferneau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Philip Ferneau | 2 | 6 |
| Thomas J. Schuetz | 2 | 2 |
| Carl Gordon | 1 | 24 |
| Garheng Kong | 1 | 16 |
| Kevin Bitterman | 1 | 15 |
| DAVID SHAW | 1 | 12 |
| Jonathan Silverstein | 1 | 10 |
| Ben Auspitz | 1 | 9 |
| Stephen Squinto | 1 | 8 |
| Errik Anderson | 1 | 8 |
| CARL L. GORDON | 1 | 7 |
| Reza Zadno | 1 | 7 |
| Doug Cole | 1 | 6 |
| Gilbert H. Kliman | 1 | 5 |
| Anthony J. Natale | 1 | 5 |
| DAVID E. SHAW | 1 | 5 |
| Julie Sunderland | 1 | 5 |
| Joseph Mandato | 1 | 5 |
| Edward McNamara | 1 | 4 |
| Yumin Choi | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.